Navigation Links
WuXi PharmaTech Announces First-Quarter 2011 Results
Date:5/10/2011

d expenses

10,922

20,548Deferred revenue

9,437

8,816Advanced subsidies

3,596

4,460Other taxes payable

4,699

2,790Convertible notes

35,864

--Other current liabilities

9,592

7,891   Total current liabilities94,019

59,568Non-current liabilities:Long-term debt, excluding current portion

1,791

1,852Advanced subsidies

3,338

2,934Convertible notes

--

35,864Other non-current liabilities

4,614

5,085   Total non-current liabilities9,743

45,735   Total liabilities103,762

105,303Equity:Ordinary shares ($0.02 par value, 5,002,550,000 authorized as of December 31, 2010 and March 31, 2011; 560,972,080 and 565,840,984 issued and outstanding as of December 31, 2010 and March 31, 2011, respectively)

11,317

11,219Additional paid-in capital

366,618

332,913Retained earnings

40,403

22,180Accumulated other comprehensive income

29,975

26,518   Total equity418,313

392,830 Total liabilities and equity522,075

498,133WUXI PHARMATECH (CAYMAN) INC.UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS(In thousands of U.S. dollars, except ADS data and per ADS data) Three Months Ended March 31, 20112010% ChangeNet revenues:Laboratory Services

75,218

66,998

12%Manufacturing Services

18,337

13,604

35%Total net revenues93,555

80,602

16%Cost of revenues:Laboratory Services

(45,414)

(39,285)

16%Manufacturing Services

(13,447)

(10,899)

23%Total cost of revenues(58,861)

(50,184)

17%Gross profit:Laboratory Services

29,804

27,713

8%Manufacturing Services

4,890

2,705

81%Total gross profit34,694

30,418

14%Operating expenses:Selling and
'/>"/>

SOURCE WuXi PharmaTech (Cayman) Inc
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related medicine technology :

1. Pharmatech Teams up With Systems Medicine LLC and the Sarcoma Foundation of America for a Phase II Myxoid Liposarcoma Trial
2. Pharmatech, Inc. Contracts for Five New Just-in-Time Clinical Trials
3. WuXi PharmaTech Included in the Deloitte Technology Fast 500 Asia Pacific 2009 List for the Sixth Consecutive Year
4. WuXi PharmaTech Schedules Fourth-Quarter 2009 Earnings Release
5. WuXi PharmaTech Passes EMEA Inspection of Its GMP Manufacturing and Analytical Testing Facilities in Shanghai
6. WuXi PharmaTech Enters into Collaboration with J&JPRD, a division of Janssen Pharmaceutica for Preclinical Services and Training
7. WuXi PharmaTech Schedules First-Quarter 2010 Earnings Release
8. WuXi PharmaTech Announces First-Quarter 2010 Results
9. WuXi PharmaTech Appoints Hao Zhou as Chief Financial Officer
10. WuXi PharmaTech Well Positioned to Continue Growing as Independent Company; Will Receive Breakup Fee of $30 million
11. WuXi PharmaTech RESCHEDULES Second-Quarter 2010 Earnings Conference Call
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2015)... ( http://www.researchandmarkets.com/research/vzhr6h/video ) has announced the addition of ... Growth, Trends and Forecast 2014 - 2020" report to ... of fascination since the era of the cold war between ... Russia. Earlier even a small glimpse of human form was ...
(Date:1/23/2015)... BETHESDA, Md. , Jan. 23, 2015  Northwest Biotherapeutics, Inc. ... developing DCVax® personalized immune therapies for operable and inoperable solid ... will present at the 7 th Annual Phacilitate Immunotherapy ... NW Bio,s presentation at Phacilitate will take place on January ...
(Date:1/23/2015)... 23, 2015  Pete Rose, baseball,s all-time hits leader, is the ... reliever Myoflex, Ducere Pharma has announced. "Pete,s a ... to have him on board with Myoflex," said Ducere Pharma ... legendary player who is known across all generations. The passion ...
Breaking Medicine Technology:Video Telemedicine Market- Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020 2Video Telemedicine Market- Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020 3NW Bio To Present At The 7th Annual Phacilitate Immunotherapy Forum 2NW Bio To Present At The 7th Annual Phacilitate Immunotherapy Forum 3Pete Rose bets on Myoflex to relieve aches and pains 2
... (Nasdaq: VRUS ) announced today that dosing ... (SAD) study in healthy volunteers with PSI-7851, a second ... (HCV). Pharmasset filed an Investigational New Drug Application (IND) ... quarter."This is a significant milestone for Pharmasset. PSI-7851 is ...
... 30 A new study, published in the ... as little as 8 grams (1/3 ounce) of "Sun ... fat percentage, serum total cholesterol, and fasting blood glucose ... of "Sun Chlorella A" tablets each morning and evening. ...
Cached Medicine Technology:Pharmasset Initiates First Time in Human Study of PSI-7851 for the Treatment of Hepatitis C (HCV) 2Pharmasset Initiates First Time in Human Study of PSI-7851 for the Treatment of Hepatitis C (HCV) 3First Human Study to Show 'Sun Chlorella A' Supports Heart Health 2
(Date:1/22/2015)... 2015 Liberty University has received accreditation for ... from the Council for Accreditation of Counseling & Related ... Center for Counseling & Family Studies , is under ... university’s new School of Behavioral Sciences. Prior to the formation ...
(Date:1/22/2015)... Padre Murphy's and Owner Tom Boyle in Glendale, AZ ... Alliance (PPHA). The PPHA's passion for others' well-being and ... greats, treated for obstructive sleep apnea (OSA) has propelled them ... in the valley. The most recent plans for an event ...
(Date:1/22/2015)... (PRWEB) January 23, 2015 AngelWeddingDress, the ... of 2015 maternity wedding dresses. View website ... are looking for maternity wedding dresses online for a ... gowns with high quality for them. Its maternity wedding ...
(Date:1/22/2015)... released a new blog post explaining the main features of ... Auto insurance quotes help many drivers find the best coverage ... an agent or visit an agency for price information. These ... http://autocarinsurancebest.com/ . , Every business who relies heavily on transportation ...
(Date:1/22/2015)... 2015 Yesterday, Senator Holly Mitchell ... Kristin Olsen (R-Modesto) were honored by the California ... biotechnology, biomedical science, medical device and pharmaceutical innovation ... the “2014 Life Sciences Champion” award from CHI ...
Breaking Medicine News(10 mins):Health News:Liberty University's Resident Master’s Counseling Program Receives CACREP Accreditation 2Health News:Padre Murphy's Holds NFL Retired Players Association Party Star Studded Event With Bud Light and Pro Player Health Alliance Sponsoring 2Health News:Padre Murphy's Holds NFL Retired Players Association Party Star Studded Event With Bud Light and Pro Player Health Alliance Sponsoring 3Health News:AngelWeddingDress Has Recently Released Its Collection Of 2015 Maternity Wedding Dresses 2Health News:Commercial Auto Insurance Provides Several Important Features! 2Health News:California Biomedical Community Honors Senator Holly Mitchell, Assemblymembers Susan Bonilla & Kristin Olsen 2Health News:California Biomedical Community Honors Senator Holly Mitchell, Assemblymembers Susan Bonilla & Kristin Olsen 3
... have confirmed that 75 people have so far succumbed to ... of Assam like wildfire. Till date 335,000 people have been ... people have died of cerebral malaria since the disease struck ... Minister Bhumidhar Barman said. Assam, which has a population of ...
... by the West Virginia University (WVU) Hospitals in US, which ... small intestine if not the whole stomach accurately. // ... is encapsulated in a pill the size of a large ... travels through the small intestine, reported the online edition of ...
... to choice, most Americans prefer a sandbag workout when compared ... that has brought into focus the latest in fitness craze ... to lift a comparable load to what workers of the ... are encouraged to ‘heave-ho their way to fitness’ by moving ...
... directed at B-cells could turn out be more effective ... disease arising out of an auto immune disorder.// ... form of biologic therapy for treatment of rheumatoid arthritis ... patients who exhibit resistance to conventional DMARDs. The effect, ...
... frequently report sick due to respiratory problems, and it ... occupational asthma every year. Prolonged exposure to dust or ... ,Alveolitus or 'occupational asthma’ is triggered by constant exposure ... the lung. It is said that the scarring ...
... in 2004 the sales of Celebrex was $3.3 billion worldwide. ... the company stopped advertising//. But 16 months later the has ... sales of the drug, which plunged last year during the ... warning and also had ingredients that could boost it sales. ...
Cached Medicine News:Health News:B-Cell Biologic Therapy Could Revolutionize Rheumatoid Arthritis Treatment 2Health News:B-Cell Biologic Therapy Could Revolutionize Rheumatoid Arthritis Treatment 3
... The CoaguChek Pro is a ... of the coagulation parameters PT, APTT, ... professional use in hospitals and medical ... e.g., in cardiac catheterization laboratories, and ...
... are constructed of a patented ... polyvinyl acetal sponge. Each device ... to both surgeon and patient, ... firm enough to gently manipulate ...
... The Surgicutt family of bleeding time ... Surgicutt for adults, Surgicutt Jr. for children ... bleeding time family is engineered to perfect ... many of the variables that have previously ...
... The Haemolance safety ... healthcare professionals to obtain ... samples are frequently used ... levels but may also ...
Medicine Products: